Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
LEFKOFF KYLE
Director at Viridian Therapeutics, Inc.\DE. Filing since 22 Feb 2017.
CIK 0001191818
Company
Date
Role
Action
Shares
Amount
Of holding
VRDN
Viridian Therapeutics, Inc.\DE
10 Mar 2017
Director
Sold, plan not stated
3,300
$47.23K
0.7%
VRDN
Viridian Therapeutics, Inc.\DE
9 Mar 2017
Director
Sold, plan not stated
2,500
$35.96K
0.5%
VRDN
Viridian Therapeutics, Inc.\DE
8 Mar 2017
Director
Sold, plan not stated
5,000
$73.51K
1.1%
VRDN
Viridian Therapeutics, Inc.\DE
6 Mar 2017
Director
Sold, plan not stated
10,000
$157.46K
2.1%
VRDN
Viridian Therapeutics, Inc.\DE
28 Feb 2017
Director
Sold, plan not stated
2,258
$30.58K
0.5%
VRDN
Viridian Therapeutics, Inc.\DE
27 Feb 2017
Director
Sold, plan not stated
1,500
$20.69K
0.3%
VRDN
Viridian Therapeutics, Inc.\DE
24 Feb 2017
Director
Sold, plan not stated
6,500
$91.25K
1.3%
VRDN
Viridian Therapeutics, Inc.\DE
23 Feb 2017
Director
Sold, plan not stated
1,800
$24.57K
0.4%
VRDN
Viridian Therapeutics, Inc.\DE
22 Feb 2017
Director
Sold, plan not stated
4,102
$58.89K
0.8%
9 decisions on file.
